Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1742-4690
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Preferential targeting of conserved Gag regions after vaccination with a heterologous DNA prime Modified Vaccinia Ankara boost HIV vaccine regime ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012

Urheber
Bauer, A.
Beteiligte Personen und Organisationen
Podola, L.
Haule, A.
Sudi, L.
Nilsson, C.
Mann, P.
Missanga, M.
Kaluwa, B.
Maboko, L.
Lueer, C.
Mwakatima, M.
Aboud, S.
Bakari, M.
Currier, J.
Robb, M.
Joseph, S.
McCormack, S.
Lyamuya, E.
Wahren, B.
Sandström, E.
Biberfeld, G.
Hoelscher, M.
Kroidl, A.
Geldmacher, C.
SpringerLink (Online service)

DOI
10.1186/1742-4690-9-S2-P330
URN
urn:nbn:de:1111-2016080728593
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Bauer, A.
  • Podola, L.
  • Haule, A.
  • Sudi, L.
  • Nilsson, C.
  • Mann, P.
  • Missanga, M.
  • Kaluwa, B.
  • Maboko, L.
  • Lueer, C.
  • Mwakatima, M.
  • Aboud, S.
  • Bakari, M.
  • Currier, J.
  • Robb, M.
  • Joseph, S.
  • McCormack, S.
  • Lyamuya, E.
  • Wahren, B.
  • Sandström, E.
  • Biberfeld, G.
  • Hoelscher, M.
  • Kroidl, A.
  • Geldmacher, C.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Gags Gags Gags

Gags Gags Gags

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen

Preferential targeting of co-evolving Gag residues in long-term non progressors

Preferential targeting of co-evolving Gag residues in long-term non progressors

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees

OA04-02. Strong HIV-specific CD4 and CD8 T-lymphocyte proliferation in HIV-1 DNA prime/modified vaccinia virus Ankara (MVA) heterologous boost vaccinees

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost

Gags

Archivale

Gags

GAG

Graffiti | Streetart

GAG

Gags

Gags

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen

Verbundene Objekte